# A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

> **NCT07219043** · PHASE2 · RECRUITING · sponsor: **Biogen** · enrollment: 81 (estimated)

## Conditions studied

- Microvascular Inflammation

## Interventions

- **DRUG:** Felzartamab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07219043
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-05
- **Primary completion:** 2028-02-10
- **Final completion:** 2028-02-10
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07219043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07219043, "A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07219043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*